CelLBxHealth plc Stock
Stocks
CLBX
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.250 GBX | 0.00% |
|
-9.09% | +13.64% |
| 07-15 | Beeks in "strong" year; Iofina output up | AN |
| 07-15 | CelLBxHealth plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 14.21M 19.06M 16.71M 15.45M 26.8M 1.84B 27.23M 185M 72.4M 899M 71.58M 70.02M 3.1B | P/E 2026 * |
-0.54x | P/E 2027 * | -13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 12.61M 16.92M 14.83M 13.71M 23.78M 1.63B 24.16M 164M 64.24M 798M 63.52M 62.14M 2.75B | EV / Sales 2026 * |
0.58x | EV / Sales 2027 * | 0.41x |
| Free-Float |
94.31% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CelLBxHealth plc
| 16/10/25 | Angle names Peter Collins as interim CEO | AN |
| 28/05/25 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 23/01/25 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 14/09/23 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 24/01/22 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 week | -9.09% | ||
| Current month | -18.03% | ||
| 1 month | -28.57% | ||
| 3 months | +38.89% | ||
| 6 months | +39.20% | ||
| Current year | +13.64% |
| 1 week | 1.2 |  | 1.53 |
| 1 month | 1.2 | | 1.69 |
| Current year | 0.85 | | 2.8 |
| 1 year | 0.85 | | 8 |
| 3 years | 0.85 | | 37.4 |
| 5 years | 0.85 | | 163.75 |
| 10 years | 0.85 | | 163.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 01/01/1999 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2025 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Klaas de Boer
BRD | Director/Board Member | 61 | 12/01/2026 |
Jan Groen
CHM | Chairman | 67 | 22/05/2023 |
Ben Hart
BRD | Director/Board Member | 39 | 12/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Buy | Chief Financial Officer | 2,500,000 | 0.7749% | ||
| 19/12/25 | Buy | Chairman | 5,000,000 | 1.5497% | ||
| 19/12/25 | Buy | Chief Executive Officer | 5,000,000 | 1.5497% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -9.09% | -80.77% | -91.07% | 19.11M | |
| -2.47% | -1.90% | +15.75% | -25.65% | 17.27B | |
| +1.64% | -5.48% | +0.79% | +91.39% | 1.57B | |
| -4.60% | -7.32% | -34.85% | -80.45% | 1.19B | |
| +1.29% | -4.72% | -37.01% | +15.19% | 999M | |
| -0.64% | +2.18% | -28.81% | -52.65% | 644M | |
| -1.79% | -5.76% | -41.68% | -57.20% | 532M | |
| +0.66% | -1.67% | +46.69% | -54.40% | 445M | |
| 0.00% | +0.64% | -54.33% | -58.66% | 382M | |
| +1.09% | +7.51% | -18.78% | -22.74% | 364M | |
| Average | -0.48% | -3.23% | -23.30% | -33.63% | 2.34B | |
| Weighted average by Cap. | -1.92% | -4.45% | +6.23% | -21.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.65M 29.05M 25.47M 23.54M 40.85M 2.8B 41.5M 281M 110M 1.37B 109M 107M 4.72B | 37.75M 50.66M 44.4M 41.05M 71.23M 4.89B 72.37M 491M 192M 2.39B 190M 186M 8.24B |
| Net income | -8.55M -11.47M -10.06M -9.3M -16.13M -1.11B -16.39M -111M -43.58M -541M -43.09M -42.15M -1.87B | -1.85M -2.48M -2.18M -2.01M -3.49M -239M -3.55M -24.05M -9.43M -117M -9.32M -9.12M -404M |
| Net Debt | -1.6M -2.15M -1.88M -1.74M -3.02M -207M -3.07M -20.8M -8.15M -101M -8.06M -7.89M -349M | 1.4M 1.88M 1.65M 1.52M 2.64M 181M 2.68M 18.2M 7.14M 88.65M 7.06M 6.9M 305M |
Employees
119
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | GBX 1.250 | 0.00% | 384,599 |
| 17/07/26 | GBX 1.250 | 0.00% | 894,293 |
| 16/07/26 | GBX 1.250 | -7.41% | 2,055,445 |
| 15/07/26 | GBX 1.350 | -3.57% | 924,436 |
| 14/07/26 | GBX 1.400 | +1.82% | 4,999,258 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0125GBP
Average target price
0.0400GBP
Spread / Average Target
+220.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
Select your edition
All financial news and data tailored to specific country editions
